Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease

This study aimed to reveal the prevalence of sodium-glucose co-transporter 2 (SGLT2) inhibitor treatment and its association with restenosis risk in patients with diabetes mellitus undergoing endovascular ther...

Source: Cardiovascular Diabetology - October 5, 2023 Category: Cardiology Authors: Mitsuyoshi Takahara, Yoshimitsu Soga, Masahiko Fujihara, Osamu Iida and Daizo Kawasaki Tags: Research Source Type: research